Literature DB >> 22894485

Analysis of second-harmonic-generation microscopy in a mouse model of ovarian carcinoma.

Jennifer M Watson1, Photini F Rice, Samuel L Marion, Molly A Brewer, John R Davis, Jeffrey J Rodriguez, Urs Utzinger, Patricia B Hoyer, Jennifer K Barton.   

Abstract

Second-harmonic-generation (SHG) imaging of mouse ovaries ex vivo was used to detect collagen structure changes accompanying ovarian cancer development. Dosing with 4-vinylcyclohexene diepoxide and 7,12-dimethylbenz[a]anthracene resulted in histologically confirmed cases of normal, benign abnormality, dysplasia, and carcinoma. Parameters for each SHG image were calculated using the Fourier transform matrix and gray-level co-occurrence matrix (GLCM). Cancer versus normal and cancer versus all other diagnoses showed the greatest separation using the parameters derived from power in the highest-frequency region and GLCM energy. Mixed effects models showed that these parameters were significantly different between cancer and normal (P<0.008). Images were classified with a support vector machine, using 25% of the data for training and 75% for testing. Utilizing all images with signal greater than the noise level, cancer versus not-cancer specimens were classified with 81.2% sensitivity and 80.0% specificity, and cancer versus normal specimens were classified with 77.8% sensitivity and 79.3% specificity. Utilizing only images with greater than of 75% of the field of view containing signal improved sensitivity and specificity for cancer versus normal to 81.5% and 81.1%. These results suggest that using SHG to visualize collagen structure in ovaries could help with early cancer detection.

Entities:  

Mesh:

Year:  2012        PMID: 22894485      PMCID: PMC3389559          DOI: 10.1117/1.JBO.17.7.076002

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  50 in total

1.  Factors influencing serum CA125II levels in healthy postmenopausal women.

Authors:  D K Pauler; U Menon; M McIntosh; H L Symecko; S J Skates; I J Jacobs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

2.  Receiver operating characteristic curves and their use in radiology.

Authors:  Nancy A Obuchowski
Journal:  Radiology       Date:  2003-10       Impact factor: 11.105

Review 3.  Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.

Authors:  Ajay P Singh; Shantibhusan Senapati; Moorthy P Ponnusamy; Maneesh Jain; Subodh M Lele; John S Davis; Steven Remmenga; Surinder K Batra
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

4.  Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.

Authors:  Charlotte H Clarke; Christine Yip; Donna Badgwell; Eric T Fung; Kevin R Coombes; Zhen Zhang; Karen H Lu; Robert C Bast
Journal:  Gynecol Oncol       Date:  2011-06-25       Impact factor: 5.482

5.  Dual modality imaging of a novel rat model of ovarian carcinogenesis.

Authors:  Elizabeth M Kanter; Ross M Walker; Samuel L Marion; Molly Brewer; Patricia B Hoyer; Jennifer K Barton
Journal:  J Biomed Opt       Date:  2006 Jul-Aug       Impact factor: 3.170

6.  7,12-dimethylbenz[a]anthracene induces sertoli-leydig-cell tumors in the follicle-depleted ovaries of mice treated with 4-vinylcyclohexene diepoxide.

Authors:  Zelieann R Craig; John R Davis; Samuel L Marion; Jennifer K Barton; Patricia B Hoyer
Journal:  Comp Med       Date:  2010-02       Impact factor: 0.982

7.  Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy.

Authors:  Oleg Nadiarnykh; Ronald B LaComb; Molly A Brewer; Paul J Campagnola
Journal:  BMC Cancer       Date:  2010-03-11       Impact factor: 4.430

8.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  Usha Menon; Aleksandra Gentry-Maharaj; Rachel Hallett; Andy Ryan; Matthew Burnell; Aarti Sharma; Sara Lewis; Susan Davies; Susan Philpott; Alberto Lopes; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Mourad W Seif; Ian Scott; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Nazar N Amso; Simon Leeson; Derek Cruickshank; Alistair McGuire; Stuart Campbell; Lesley Fallowfield; Naveena Singh; Anne Dawnay; Steven J Skates; Mahesh Parmar; Ian Jacobs
Journal:  Lancet Oncol       Date:  2009-03-11       Impact factor: 41.316

9.  Three-dimensional power Doppler ultrasound in ovarian cancer and its correlation with histology.

Authors:  Iris Ohel; Eyal Sheiner; Barak Aricha-Tamir; Benjamin Piura; Mihai Meirovitz; Tali Silberstein; Reli Hershkovitz
Journal:  Arch Gynecol Obstet       Date:  2009-11-04       Impact factor: 2.344

Review 10.  Prophylactic oophorectomy in premenopausal women and long-term health.

Authors:  Lynne T Shuster; Bobbie S Gostout; Brandon R Grossardt; Walter A Rocca
Journal:  Menopause Int       Date:  2008-09
View more
  12 in total

1.  Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer.

Authors:  Jeremy S Bredfeldt; Yuming Liu; Carolyn A Pehlke; Matthew W Conklin; Joseph M Szulczewski; David R Inman; Patricia J Keely; Robert D Nowak; Thomas R Mackie; Kevin W Eliceiri
Journal:  J Biomed Opt       Date:  2014-01       Impact factor: 3.170

2.  Simultaneous multiplane imaging of human ovarian cancer by volume holographic imaging.

Authors:  Gabriel V Orsinger; Jennifer M Watson; Michael Gordon; Ariel C Nymeyer; Erich E de Leon; Johnathan W Brownlee; Kenneth D Hatch; Setsuko K Chambers; Jennifer K Barton; Raymond K Kostuk; Marek Romanowski
Journal:  J Biomed Opt       Date:  2014-03       Impact factor: 3.170

3.  Diagnostic potential of multimodal imaging of ovarian tissue using optical coherence tomography and second-harmonic generation microscopy.

Authors:  Weston A Welge; Andrew T DeMarco; Jennifer M Watson; Photini S Rice; Jennifer K Barton; Matthew A Kupinski
Journal:  J Med Imaging (Bellingham)       Date:  2014-07-18

4.  In vivo time-serial multi-modality optical imaging in a mouse model of ovarian tumorigenesis.

Authors:  Jennifer M Watson; Samuel L Marion; Photini F Rice; David L Bentley; David G Besselsen; Urs Utzinger; Patricia B Hoyer; Jennifer K Barton
Journal:  Cancer Biol Ther       Date:  2013-10-03       Impact factor: 4.742

5.  Applications of second-harmonic generation imaging microscopy in ovarian and breast cancer.

Authors:  Karissa Tilbury; Paul J Campagnola
Journal:  Perspect Medicin Chem       Date:  2015-04-16

6.  A Novel Intravital Imaging Window for Longitudinal Microscopy of the Mouse Ovary.

Authors:  Filip Bochner; Liat Fellus-Alyagor; Vyacheslav Kalchenko; Shiri Shinar; Michal Neeman
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

7.  Stromal alterations in ovarian cancers via wavelength dependent Second Harmonic Generation microscopy and optical scattering.

Authors:  Karissa B Tilbury; Kirby R Campbell; Kevin W Eliceiri; Sana M Salih; Manish Patankar; Paul J Campagnola
Journal:  BMC Cancer       Date:  2017-02-06       Impact factor: 4.430

8.  Multiscale anisotropy analysis of second-harmonic generation collagen imaging of mouse skin.

Authors:  Karissa Tilbury; XiangHua Han; Peter Brooks; Andre Khalil
Journal:  J Biomed Opt       Date:  2021-06       Impact factor: 3.170

Review 9.  Nonlinear optical microscopy signal processing strategies in cancer.

Authors:  Javier Adur; Hernandes F Carvalho; Carlos L Cesar; Víctor H Casco
Journal:  Cancer Inform       Date:  2014-04-02

10.  The severity of Osteogenesis imperfecta and type I collagen pattern in human skin as determined by nonlinear microscopy: proof of principle of a diagnostic method.

Authors:  Javier Adur; Lilia DSouza-Li; Marcus Vinícius Pedroni; Carlos E Steiner; Vitor B Pelegati; Andre A de Thomaz; Hernandes F Carvalho; Carlos L Cesar
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.